Universal screening or prophylactic treatment for Chlamydia trachomatis infection among women seeking induced abortions: Which strategy is more cost-effective?

Sexually Transmitted Diseases

Volumn 34, Issue 4, 2007, Pages 230-236

  Chen, Shumin ^a,c   Li, Jianhong ^a   Van Den Hoek, Anneke ^b  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b MUNICIPAL HEALTH SERVICE   (Netherlands)

^c Shandong Provincial Institute of Dermatovenereology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN;

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; FEMALE; HEALTH CARE COST; HUMAN; INDUCED ABORTION; PELVIC INFLAMMATORY DISEASE; POLYMERASE CHAIN REACTION; PROPHYLAXIS;

ABORTION, INDUCED; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHINA; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COST-BENEFIT ANALYSIS; DECISION TREES; FEMALE; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; VAGINAL SMEARS; WOMEN'S HEALTH SERVICES;

EID: 34247185994     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000233739.22747.12     Document Type: Article

References (38)

1. Taylor-Robinson D. Chlamydia trachomatis and sexually transmitted disease. BMJ 1994; 308:150-151.
2. Piot P, Islam MQ. Sexually transmitted diseases in the 1990s, global epidemiology and challenges for control. Sex Transm Dis 1994; 21:S7-S13.
3. Groseclose SL, Zaidi AA, DeLisle SJ, et al. Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United States, 1996. Sex Transm Dis 1999; 26:339-344.
4. Parish WL, Laumann EO, Cohen MS, et al. Population-based study of chlamydial infection in China: A hidden epidemic. JAMA 2003; 289:1265-1273.
5. Stamm WE. Toward control of sexually transmitted chlamydial infections. Ann Intern Med 1993; 119:432-434.
6. Westrom L, Riduan J, Reynolds G, Hagdu A, Thompson SE. Pelvic inflammatory disease and fertility: A cohort of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992; 19:185-192.
7. Hillis SD, Joesoef R, Marchbanks PA, Wasserheit JN, Cates W Jr, Westrom L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993; 168:1503-1509.
8. Schachter J, Grossman M, Sweet RL, Holt J, Jordan C, Bishop E. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA 1986; 255:3374-3377.
9. Washington AE, Johnson RE, Sanders LL. Chlamydia trachomatis infections in the United States: What are they costing us? JAMA 1987; 257:2070-2072.
10. Addiss DG, Vaughn ML, Ludka D, Pfister J, Davis JP. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin. Sex Transm Dis 1992; 20:28-35.
11. Chout RT, Vaton S, Duval-Violton D, Leguyader-Despres D, Orfila J. Screening for Chlamydia trachomatis infection in pregnant women in Martinique. Sex Transm Dis 1995; 22:221-227.
12. Mangione-Smith R, O'Leary J, McGlynn E. Health and cost - benefits of chlamydia screening in young women. Sex Transm Dis 1999; 26:309-316.
13. Miller WC. Screening for chlamydial infection: A model program based on prevalence. Sex Transm Dis 1998; 25:201-209.
14. Hillis S, Black C, Newhall J, Waish C, Groseclose SL. New opportunities for chlamydia prevention: Applications of science to public health practice. Sex Transm Dis 1995; 22:197-202.
15. Kamwendo F, Forslin L, Bodin L, Danielsson D. Decreasing incidences of gonorrhea- and chlamydia-associated acute pelvic inflammatory disease. A 25 year study from an urban area of central Sweden. Sex Transm Dis 1996; 23:384-391.
16. Genc M, Mardh AA. A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. Ann Intern Med 1996; 124:1-7.
17. Marrazzo JM, Celum CL, Hillis SD, Fine D, DeLisle S, Handsfield HH. Performance and cost-effectiveness analysis of selective screening criteria for Chlamydia trachomatis infection in women: Implications for a national chlamydia control strategy. Sex Transm Dis 1997; 24:131-141.
18. Paavonen J, Puolakkainen M, Paukku M, Sintonen H. Cost - benefit analysis of first-void urine Chlamydia trachomatis screening program. Obstet Gynecol 1998; 92:292-298.
19. Howell MR, Quinn TC, Gaydos CA. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies. Ann Intern Med 1998; 25:128-184.
20. Howell MR, Quinn TC, Brathwaite W, Gaydos CA. Screening women for Chlamydia trachomatis in family planning clinics: The cost-effectiveness of DNA amplification assays. Sex Transm Dis 1998; 25:108-117.
21. Howell MR, Gaydos JC, McKee KT Jr, Quinn TC, Gaydos CA. Control of Chlamydia trachomatis infection in female recruits: Cost-effective screening and treatment in training cohorts to prevent pelvic inflammatory disease. Sex Transm Dis 1999; 26:519-526.
22. Honey E, Augood C, Templeton A, et al. Cost effectiveness of screening for Chlamydia trachomatis: A review of published studies. Sex Transm Infect 2002; 78:406-412.
23. Friedman HB, Gift TL, Susanti I, Wasserheit JN. Risk-based versus alternative algorithms for antibiotic prophylaxis among women seeking early suction abortion: A cost-effectiveness simulation. Sex Transm Dis 2001; 28:714-724.
24. Chen SM, van den Hoek A, Shao CG, et al. Prevalence of and risk indicators for STIs among women seeking induced abortions in two urban family planning clinics in Shandong province, People's Republic of China. Sex Transm Infect 2002; 78:e3.
25. Peeling RW, Toye B, Jessamine P, Gemmill I. Pooling of urine specimen for PCR testing: A cost-saving strategy for Clamydia trachomatis control programmes. Sex Transm Infect 1998; 74:66-70.
26. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334:1362-1366.
27. Hu D, Edward W, Goldie SJ. Screening for Chlamydia trachomatis in women 15 to 29 years of age: A cost-effectiveness analysis. Ann Intern Med 2004; 141:501-513.
28. Blackwell A, Thomas PD, Wareham, Emery SJ. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet 1993; 342:206-210.
29. Hellberg D, Mogilevkina I, Andeers P. Sexually transmitted diseases and gynecologic symptoms and signs in women with a history of induced abortion. Sex Transm Dis 1999; 26:197-200.
30. Darij E, Stralin EB, Nilsson S. The prophylactic effect of doxycycline on postoperative infection rate after first-trimester abortion. Obstet Gynecol 1987; 70:755-758.
31. Sonne-Holm S, Heisterbeg L, Hebjorn S, Dying-Andersen K, Andersen JT, Hejl BL. Prophylactic antibiotics in first-trimester abortions: A clinical controlled trial. Am J Obstet Gynecol 1981; 139:693-696.
32. Hemsell DL. Prophylactic antibiotics in gynecologic and obstetric surgery. Rev Infect Dis 1991; 13:S821-841.
33. Uthayakumar SM, Tenuwara WF, Maiti HF. Is it evidence-based practice? Prophylactic antibiotics for termination of pregnancy to minimize post-abortion pelvic infection? Int J STD AIDS 2000; 11:168-169.
34. Sawaya GF, Grady D, Kerlikowske KK. Antibiotics at the time of induced abortion: The case for universal prophylaxis based on meta-analysis. Obstet Gynecol 1996; 87:884-890.
35. Rustomjee R, Kharsany AB, Connolly CA, Karim SS. A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resources-poor setting. J Antimicrob Chemother 2002; 49:875-878.
36. van Valkengoed IG, Morre SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes: Implications for cost-effectiveness analyses. Int J Epidemiol 2004; 33:416-425.
37. Bocke AJ, van Bergen JE, Morre SA, van Everdingen JJ. The risk of pelvic inflammatory disease associated with urogenital infection with Chlamydia trachomatis; literature review. Ned Tijdschr Geneeskd 2005; 16:878-884.
38. Cameron ST, Sutherland S. Universal prophylaxis compared with screen-and-treat for Chlamydia trachomatis prior to termination of pregnancy. BJOG 2002; 109:606-609.